logo

For the Inventor, By the Inventor

Lansdale, PA, United States of America

Adel M Naylor-Olsen

This inventor holds 11 USPTO granted patents. Top assignee: Merck + Co., Inc.. Active years: 1997-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adel M Naylor-Olsen. Retrieved from https://idiyas.com/inventor/adel-m-naylor-olsen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 4.5

ph-index = 6

Forward Citations = 77(Granted Patents)


Company Filing History:

goldMedal11 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1997-2003

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6610692 - Thrombin inhibitors (2003-08-26),
2. 6376499 - Thrombin inhibitors (2002-04-23),
3. 6211184 - Integrin antagonists (2001-04-03),
4. 6133297 - Thrombin inhibitors (2000-10-17),
5. 6093717 - Imidazopyridine thrombin inhibitors (2000-07-25),
6. 5981546 - Integrin antagonists (1999-11-09),
7. 5932606 - Pyrazinone, pyridinone, piperidine and pyrrolidine thrombin inhibitors (1999-08-03),
8. 5872138 - Thrombin inhibitors (1999-02-16),
9. 5792761 - Thrombin inhibitors (1998-08-11),
10. 5744486 - Pyridinone thrombin inhibitors (1998-04-28),
11. 5668289 - Pyridinone thrombin inhibitors (1997-09-16),

Title: The Innovations of Adel M Naylor-Olsen

Introduction

Adel M Naylor-Olsen is a prominent inventor based in Lansdale, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombin inhibitors. With a total of 11 patents to his name, Naylor-Olsen has established himself as a key figure in innovation.

Latest Patents

His latest patents focus on thrombin inhibitors, which are crucial in the treatment of various medical conditions. These innovations demonstrate his commitment to advancing healthcare through scientific research and development.

Career Highlights

Naylor-Olsen is currently employed at Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to collaborate with some of the brightest minds in the industry, further enhancing his contributions to medical science.

Collaborations

Some of his notable coworkers include Philip E Sanderson and Bruce D Dorsey. Their collaborative efforts have led to groundbreaking advancements in the field of thrombin inhibitors.

Conclusion

Adel M Naylor-Olsen's work exemplifies the spirit of innovation in the pharmaceutical industry. His contributions continue to impact healthcare positively, showcasing the importance of research and collaboration in developing effective medical solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…